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carbamazepine and clofibric acid] in aqueous medium at various pHs by using a batch photoreactor and a photocatalytic membrane reactor working
in recirculation regimewas carried out. Polycrystalline TiO2 was used as the photocatalyst, and different membranes (NTR 7410, PANGKSSHV3/
T, N 30 F, NF PES 10) were tested. A different adsorption of the substrates onto the catalyst surface was observed owing to the hydrophilic/
hydrophobic character of the catalyst, depending on the pH. The photodegradation of the seven molecules in the batch reactor was successfully
carried out and the behaviour was in accordance with pseudo-first order kinetics. Furosemide and ranitidine were selected to carry out the study of
rejection and photodegradation in the hybrid membrane system. The permeate flux of the treated water was in the 31.5–60.0 L/(h m2) range for
NTR 7410 membrane, whereas rejection values in the range 10–60% for furosemide and 5–30% for ranitidine in the dark (without photoreaction)
were found. The degradation in the hybrid membrane photoreactor showed that the photocatalyst was retained by the membrane in the reaction
ambient, while the membrane rejection towards the pollutants was not very satisfactory. A net decrease of the rejection down to 0 was observed in
the contemporary presence of light, photocatalyst and oxygen.
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A large amount of drugs is consumed in each part of the
world. For example it is estimated that in Germany in 1995,
more than 100 t of drugs [1] were prescribed by doctors to their
patients. Recent estimations indicate that in Europe, which
holds about 26% of the international pharmaceutical market,
more than 2000 different pharmaceutical products are used [1]
while annual consumption of antibiotic type substances is
similar in quantity to that of some pesticides [2]. The drugs
assumed and not metabolized by the organism, are excreted
through urine and faeces [3]. The present tendency to
synthesize drugs resistant to common biotransformation
mechanisms to protract their persistence in organisms, results* Corresponding author. Tel.: +39 0984 496 699; fax: +39 0984 496 655.
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doi:10.1016/j.cattod.2005.11.091in obtaining very stable molecules. This means resistance to
chemical and biological degradation with a consequent increase
of these products in the environment and especially in surface
waters. Traditional treatment processes may prove ineffective
for the removal of these substances [1], thus pharmaceuticals
and hormones such as antimicrobial agents and steroids [4] and
antibiotics [2] have been detected in concentrations of somemg/
L in the waters deriving from municipal treatment plants in
Germany. Great part of the antibiotics reported in Ref. [2] have
also been discovered in Brazil in the effluents of treatment
plants as well as in various rivers in concentrations from 0.1 to
1 mg/L [4]. The presence of some pharmaceutical substances
even in natural waters in concentrations of about 1 mg/L has
been allowed [5–7]. Zuccato et al. [8] carried out an extensive
investigation on the presence of drugs in drinking and surface
waters also in the Lombardy region of Italy. Transformation of
antibiotics [7,9–11] has been widely studied. At present only
for few pharmaceutical substances (aspirin, caffeine, clofibrate,
ciclofosphamide, oestrogens, ibuprofen, naproxen) literature
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Moreover, most studies refer to the toxicity for living organisms
of antibiotic type substances [13–19] showing effects in the
endocrine system of fish [20] even at levels of some ng/L. The
results so far reported suggest considering the presence of
pharmaceutical substances in the environment a risk for human
health and for living species, even at very low concentration
levels [21]. For example, clofibric acid, used as a regulator of
lipids in the blood, shows an ‘‘estimated persistence in the
environment of 21 years and is still detected in lakes and rivers
after it was withdrawn from the market’’ [22].
Various researches [23–26] report that in the natural aquatic
environment direct or indirect type of photodegradation
processes can occur. Indirect type processes are due to the
interaction of sunlight with photosensible species such as
nitrates, humic acids and metal ions capable of producing
highly reactive chemical species, which activates the degrada-
tion of the pollutants.
In this context it is useful to apply various technologies to
purify aqueous civil and industrial effluents containing
pharmaceutical substances. Among them, advanced oxidation
processes (AOP) have been the subject of major interest in
recent years. These processes are characterized by the
formation of OH radicals, which ensure high reactivity and
low selectivity, as they are required for the degradation of
different pollutants. Heterogeneous photocatalysis represents
an example of AOP capable of achieving a complete oxidation
of organic and inorganic species, including also pharmaceutical
substances. It takes advantage of some semiconductor solids,
which can be used as photocatalysts suspended in the water
effluent to be treated, or immobilised on various types of
supports. Among the various solids, polycrystalline anatase
TiO2 is largely used because of its low cost and its
(photo)stability [27,28].
Unfortunately, from an economic point of view the treatment
of polluted waters with the photocatalytic process can be
competitive, with respect to conventional processes, only under
particularly favourable circumstances.
The use of membrane technology processes, instead, has
already been demonstrated to be competitive with respect to the
other separation processes, owing to low energy cost and
environment impact [29–31]. To couple photocatalytic and
membrane processes introduces a synergy for both technolo-
gies: in particular the presence of the membrane ensures the
confining of the photocatalyst and/or the separation at
molecular level, maintaining the pollutant species in the
reacting ambient. Satisfactory results were recently obtained by
using photocatalytic membrane reactors with immobilised TiO2
and the advantage of the separation at molecular scale was
demonstrated owing to the presence of the membrane [32–34].
In addition, the membrane photoreactors allow operation in
continuous systems without the need to separate the catalyst
from the reaction ambient, the system to be easily scaled up and
high surface/volume ratios to be obtained.
Seven pharmaceuticals have been studied in this work. They
can be present in water at different concentrations depending on
their use and on their solubility: furosemide, ranitidine(hydrochloride), ofloxacine, phenazone and clofibric acid have
high solubility, while carbamazepine and naproxen have low
solubility. They are used for health benefit purposes, but they
can also exert deleterious effects at certain concentrations.
Indeed, furosemide has a diuretic effect and it has been found
not only to have a toxic effect at certain concentrations, but also
it is suspected to be carcinogenic. Ranitidine is used for ulcer
disease because it is an antagonist of H2 gastric receptors and it
reduces the secretion of chloridric acid. Ofloxacine is an
antibiotic inhibitor of girase (a DNA enzyme): both these
pharmaceuticals at certain concentrations are toxic for humans.
Clofibric acid is an ipolidemic agent used as anticolesteric; its
pharmacological principle can produce a toxic effect on liver
inducing biliary calculi. Carbamazepine is an antiepileptic
agent used as sedative; by a toxicological point of view it can
produce serious toxic effects on liver and on the emopoietic
system. Phenazone is an antiphlogistic agent, but it could give
rise even to death when it is overdosed. Naproxen is an
antiphlogistic agent that can induce toxic effects on the lung
system.
The main aim of this study is to prove the feasibility of
photodegradation of the above drugs by using polycrystalline
TiO2 and different types of commercial nanofiltration (NF)
membranes operating at different conditions (pH, initial
concentration of pollutant, pressure, permeate flowrate) in a
membrane photoreactor working in total recirculation regime.
2. Experimental
Solutions of different commercial pharmaceuticals [furose-
mide, ranitidine (hydrochloride), ofloxacine, phenazone,
naproxen, carbamazepine and clofibric acid] provided from
Sigma–Aldrich, dissolved in ultrapure water (ELIX 5,
Millipore) were used. Their structures together with the raw
formula and molar weight are reported in Fig. 1.
TiO2 P25 Degussa (BET specific surface area: ca.
50 m2 g1; size of the primary particles: 30–50 nm) was used
as the photocatalyst for all of the photoreactivity experiments.
Commercial membranes, mainly of the nanofiltration type
(Table 1), were tested in rejection and photocatalytic
degradation experiments. The membranes after each run were
regenerated by immersing them for 15 h in 200 mL of an
aqueous solution containing 0.5% (w/w) of an enzymatic
detergent (Ultrasil 50 by Henkel).
The Pyrex annular photoreactor had a volume of 500 mL. In
order to sample and to bubble the gas, it was provided of ports in
the upper section. A 125 W medium pressure Hg lamp (Helios
Italquartz, Milan), equipped with a Pyrex cylindrical cooling
jacket, was axially positioned inside the reactor, which was
filled with the aqueous dispersion containing the pollutant. The
photocatalyst was maintained in suspension by means of a
magnetic stirrer. Oxygen was continuously bubbled by using a
horizontal microfiltration polypropylene tubular membrane
(internal diameter 0.5 cm, length 3 cm, mean pore size 0.2 mm)
in the reservoir. The cell containing the membrane was
connected to the annular photoreactor in a recirculation loop
(Fig. 2). This schemewas used in discontinuous mode but it can
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Fig. 1. Structure, formula and molar weights of the substrates used.be also used for continuous operations. The membrane (19 cm2
surface area) was placed in the bottom of the cell (95 mL
volume) on a porous disk of sintered stainless steel and it was
maintained under pressure by means of a diaphragm pump
(Cole–Palmer: Q = 360 L h1; Pmax = 14 bar) equipped with anTable 1
Main characteristics of the membranes employed
Membranes Manufacturer Characteristics
NTR 7410 Nitto Denko, Tokyo Rejection 10% with 0.2%
4.9 bar, 25 8C and pH 6.
PAN GKSS
HV3/T
GKSS, Germany Cut-off = 30 kDa; water
2 bar and 846.2 L/(h m2)
N 30 F Hoechst, Celgard, Germany Rejection 25–35% with
85–95% with 0.5% of N
water flux 40–70 L/(h m2
NF PES 10 Hoechst, Celgard, Germany Rejection 10–20% with
0.5% of Na2SO4; water flAISI 316 stainless steel head and a pulse dumping. The pressure
in the cell was regulated by means of a valve in the retentate
line. The suspension entered tangentially the cell downward
generating a turbulence, which minimised catalyst sedimenta-
tion onto the surface of the membrane and left the cell from theMaterial
NaCl at
5
Sulphonated polysulphone
flux 423.1 L/(h m2) at
at 4 bar
Polyacrylonitrile
0.2% NaCl and
a2SO4;
) at 40 bar and 20 8C
Modified polysulphone
0.5% NaCl and 40–70% with
ux 200–400 L/(h m2) at 40 bar and 20 8C
Polyetersulphone
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Fig. 2. Scheme of the systems used withmembrane and suspended catalyst: PR,
photoreactor system; MC, membrane cell; TB, thermostatic bath with cooling
water; P, pump; R, rotameter; C, graduate cylinder for permeate sampling; PG,
pressure gauge; V, valve; FT, feed tank (continuous regime); PT, product tank
(continuous regime). The dotted lines, FTand PTare used in continuous regime.top. All the tubing used was stainless steel to avoid the
adsorption of the organic species.
The oxygen concentration, the catalyst amount and the
temperature were 20 mg L1, 1 g L1 and 30 8C, respectively,
for all the tests. After 30 min of mixing in the dark (to allow the
saturation of the dispersion with oxygen and the achievement of
steady state conditions for the adsorption phenomena) the lamp
was switched on and samples were withdrawn at fixed intervals
of time.
The photodegradation and rejection experiments by using
the various pharmaceuticals were carried out in the system
shown in Fig. 2, in which a membrane cell is coupled to the
photocatalytic reactor. The rejection tests for the various
membranes (characteristics shown in Table 1) with the different
pharmaceuticals were carried out before starting the photo-
reactivity runs by using 500 mL of an aqueous solution
containing 5 or 10 mg/L of drug under pressures of 4, 6 and
8 bar. Membrane rejection (R%) was calculated as
R% = (1(Cp/Cr))  100 where Cp and Cr are the concentra-
tions of the drugs present in the permeate and in the retentate,
respectively. They were periodically analyzed and the catalyst
was added to the system and the oxygen was bubbled only when
steady state conditions were reached.
The experiments for the adsorption study of the pharma-
ceuticals on the TiO2 surface at different initial pHs were
carried out by using suspensions of 200 mL volume with aconcentration of 10 mg/L of drug and an amount of 1 g/L of
TiO2. The blank for each drug was considered the correspond-
ing solution in the absence of TiO2. The pH of the suspension or
of the solution was adjusted in the range 2–12 with 1 M
H2SO4(aq) or NaOH(aq). The concentrations of the pharmaceu-
ticals were determined by measuring the absorbance by means
of a Shimadzu UV-1601 spectrophotometer. The readings were
performed at the following absorbance maxima: 231 nm for
furosemide; 229 nm for ranitidine; 288 nm for ofloxacine;
227 nm for clofibric acid; 210 nm for carbamazepine; 240 nm
for phenazone and 230 nm for naproxen. Three milliliters of
samples were filtered by means of a membrane with a mean
pore size of 0.22 mm in order to separate the TiO2 particles
before carrying out the analyses. The pH measurements were
carried out by means of a INOLAB-TERMINAL LEVEL 3 pH-
meter by WTW (Germany).
3. Results and discussion
In order to analyze the results of the photodegradation
experiments in the membrane reactor, some tests were carried
out at various pHs to study separately the main factors involved
in the overall performance of the photoreactor, i.e. (i)
adsorption of the drugs on the TiO2 particles; (ii) degradation
of the drugs in the absence of the membrane; (iii) membrane
rejection on respect to the drugs by changing the operating
pressures; (iv) synergic effects of the above factors in the
membrane photoreactor. The tested compounds were almost
completely soluble at the various pHs in the range of
investigated concentrations (5–10 mg/L).
3.1. Adsorption tests of the drugs on the catalyst at
various pHs
All the pharmaceuticals were tested in the pH range 2–12 at
an initial concentration of 10 mg/L to observe their adsorption
behaviour on the titanium dioxide particles (1 g/L). A different
adsorption of the substrates onto the catalyst surface was
observed. Indeed, the hydrophilic/hydrophobic character of the
catalyst changed with the pH (point of zero charge, PZC, TiO2
in the pH range 4.5–6.2 [35]) and, consequently, the adsorption
changed by considering the acid–base properties of the seven
molecules, although a straightforward correlation of the extent
of adsorption and the acidity/basicity of the molecules is not
easy, owing to the complexity of their structure. In Table 2 some
selected values of adsorption percentages are reported.
Specifically, for furosemide a sigmoid decreasing adsorption
trend from pH 1.9 to 4.7 was observed; for phenazone a
negligible adsorption was observed, while for clofibric acid the
adsorption increased by decreasing the pH; for naproxen a
slight adsorption was observed at pH 11 while it increased by
decreasing the pH. As an example, in Fig. 3 the adsorption
behaviour of ofloxacine is reported. It can be deduced a higher
adsorption percentage at pH around the PZC TiO2. This finding
can be explained by taking into account that both acidic and
basic sites exist on TiO2 surface at this pH value and
consequently the molecule can interact more significantly.
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Table 3
Values of pseudo-first order rate constants, pKa and log Kow for the different
substrates
kobs (min
1) pKa1 pKa2 log Kow
pH 3 pH 11
Furosemide 3.21  102 1.13  101 3.9 9.93 2.03
Clofibric acid 3.28  102 5.93  102 – – –
Naproxen 7.86  102 4.91  101 4.2 – 3.18
Carbamazepine 1.52  101 1.54  101 13.9 – 2.45
Ranitidine 9.74  102 5.35  102 2.7 8.2 0.27
Ofloxacine 2.94  101 7.27  102 5.97 – –
Phenazone 1.74  101 1.60  101 1.4 – 1.14
Table 2
Values of adsorption percentages of the seven pharmaceuticals vs. pH
Substrate pH Adsorption (%)
Furosemide 1.9 90
1.9–4.7 Sigmoid decreasing trend
4.7 0
Ranitidine 2 < pH < 11 25.5
>11 0
Phenazone 2 < pH < 12 Negligible
Clofibric Acid 3 100
11 80
Ofloxacine 3 33
6 54
12 9
Carbamazepine 3 30
11 8
Naproxen 3 95
11 3
V = 200 mL, T = 30 8C; Co = 10 mg/L, CTiO2 ¼ 1 g=L.The adsorption percentage can be also related to the drug
solubility in water: for phenazone and clofibric acid a complete
solubility in all the pH range was observed; for carbamazepine
it was complete at pHs around 3 and 11; for naproxen the
solubility was complete at pH 11 while it decreased by
decreasing the pH. As a general trend, a high solubility of the
drug in water corresponds to a low adsorption percentage on
TiO2 particles.
3.2. Photodegradation tests in a batch photoreactor in the
absence of membrane
The photodegradation behaviour for furosemide, carbama-
zepine and naproxen at acidic and alkaline pHs (3 and 11) was
studied starting from the initial concentration of 5 mg/L, while
the concentration of 10 mg/L was chosen for the other
molecules by taking into account the different solubility inFig. 3. Ofloxacine concentrations vs. pH in the presence of TiO2 (V = 200 mL,
T = 30 8C, Co = 10 mg/L, CTiO2 ¼ 1 g=L).water (see in Table 3 the values of the logarithm of octanol/
water partition coefficients, log Kow, indicative of the solubility
in water). The used batch photoreactor is part of the scheme in
Fig. 2 without the membrane cell. The drugs concentration
versus irradiation time, for runs carried out at pHs equal to 3
and 11, are reported in Figs. 4 and 5, respectively. It can be
noticed that the concentration of the substrates decreases by
increasing the irradiation time and the behaviour is in
accordance with pseudo-first order kinetics with a good
exponential fitting of the data. The values of the observed
rate constants are reported in Table 3 together with pKa and
log Kow.
The differences in photoactivity of the various substrates at
the different pHs used probably are mainly attributable to the
fact that different equilibrium species are present in solution by
changing the initial pH. It is not easy to straightforward
correlate the photoreactivity with the physico-chemical proper-
ties of the molecules, due to their complexity and to the fact that
some of them show both acid and basic groups and/or atoms.
Anyway, an attempt can be made by taking into account their
pKa values. It is worth noting that the photodegradation observedFig. 4. Substrate concentration vs. irradiation time for runs carried out at initial
pH 3 (CTiO2 ¼ 1 g=L; CO2 ¼ 22 ppm; immersed lamp 125 W). Furosemide
(*); ranitidine (*); phenazone (&); clofibric acid (~); ofloxacine (^);
carbamazepine (&); naproxen (^).
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Fig. 6. Fluxes of ultrapure water vs. pressure. NTR 7410 (^); N 30 F (*);
GKSSHV3/T (&); NF PES 10 (&).
Fig. 5. Substrate concentration vs. irradiation time for runs carried out at initial
pH 11 (CTiO2 ¼ 1 g=L; CO2 ¼ 22 ppm; immersed lamp 125 W). Furosemide
(*); ranitidine (*); phenazone (&); clofibric acid (~); ofloxacine (^);
carbamazepine (&); naproxen (^).rate constants of carbamazepine andphenazone at pH3 and11do
not differ significantly each other, while the other molecules
show higher or lower values at the two investigated pHs.
In the first case the constancy of the values could be
explained by considering that only one main species for each
drug probably exists at the different pHs, owing to the values of
the pKas, although the molecules are very different from a
chemical point of view (for carbamazepine pKa1 > 7, for
phenazone pKa1 < 7). Consequently for each drug, the values
of kobs at the different pHs are representative only of one
principal species present, both at pH 3 and at pH 11.
The situation is different for the other molecules as the kobs
values are different: i.e. they are an order of magnitude lower
(ofloxacine) or higher (furosemide and naproxen) at alkaline
pH. This suggests a dependence of the activity changes on the
relative abundance of an acidic or a basic form of the drugs.
Moreover, by changing the pH from 3 to 11 an excess of
negative charges are generated on the photocatalytic surface
and this phenomenon can influence the photodegradation rate.
The obtained activity data are not related with the results of
the adsorption tests of the different drugs performed at different
initial pHs in the dark. This finding indicates that both the
adsorption equilibria and the active sites on semiconductor
surface dramatically change under irradiation, influencing the
interaction between the photocatalyst and the substrates.
As a general consideration the reported results suggest that
not only the (photo)adsorbed species but also the species
present in various acid–base forms in the solid–liquid interface,
i.e. just close to the surface but still dissolved in water, play an
essential role in the photoreactivity steps.
In order to correctly compare the data presented in Figs. 4
and 5, the direct photolysis (homogeneous phase) under the
same experimental conditions used for the heterogeneous
system should be taken into account. For phenazone,carbamazepine and clofibric acid it was observed a same
percentage of photodegraded drug by irradiating the homo-
geneous system six times longer for phenazone and clofibric
acid and 2.5 longer for carbamazepine. Thus, the photode-
gradation by direct photolysis can be neglected.
3.3. Influence of pH and operative pressure on the
membrane rejection (R)
Among the tested drugs, furosemide and ranitidine were
selected to carry out the study of rejection and photodegrada-
tion by using the hybrid membrane system. As can be deduced
from the definition given before, a rejection of 100%means that
the molecule is completely retained by the membrane. The
influence of pH (acidic, neutral, basic) and operative pressure
on the rejection was studied by using the four membranes
reported in Table 1. Preliminary measurements of the fluxes
with ultrapure water at three different pressures were carried
out and their values are reported in Fig. 6. It can be observed
that the four membranes cover a wide range of permeate flux.
The rejection percentages are reported in Tables 4 and 5 for
furosemide and ranitidine, respectively. From the analysis of
the data it is possible to notice the following general
indications: (i) R% generally increases with the pressure for
a same pH. This phenomenon means that the permeate flux of
water increases with the pressure more than that of the drugs
and consequently the concentration of the drugs in the permeate
decreases; (ii) a variable polarized drug layer is probably
formed on the membrane surface of the retentate zone causing a
variable resistance to the passage of molecules of the two drugs
through the membrane pores. Indeed the linear structure of the
ranitidine molecule can explain the lower rejection observed
with respect to furosemide; (iii) the behaviour of R% toward
furosemide and ranitidine at a fixed pressure could depend on
the chemical properties of the substrates and of the materials
constituting the different membranes. At acidic and alkaline
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Table 4
Rejection percentages for furosemide
Membranes Pressure
4 bar 6 bar 8 bar
Acidic pH
(2.5–3.0)
Neutral pH
(6.5–7.1)
Basic pH
(11.0–11.3)
Acid pH
(2.5–3.0)
Neutral pH
(6.5–7.1)
Basic pH
(11.0–11.3)
Acid pH
(2.5–3.0)
Neutral pH
(6.5–7.1)
Basic pH
(11.0–11.3)
NTR 7410 9.8 52.9 54.0 21.8 54.0 57.5 34.5 56.3 62.1
PAN GKSS HV3/T 2.3 5.1 11.5 2.7 5.1 12.0 3.3 5.1 13.2
N 30 F 40.0 48.5 20.0 44.5 61.6 28.8 50.0 75.3 36.7
NF PES 10 0.0 27.3 81.4 4.4 40.0 81.4 8.8 51.8 81.4
Table 5
Rejection percentages for ranitidine
Membranes Pressure
4 bar 6 bar 8 bar
Acidic pH
(2.5–3.0)
Neutral pH
(6.2–7.0)
Basic
(11.0–11.1)
Acidic pH
(2.5–3.0)
Neutral pH
(6.2–7.0)
Basic pH
(11.0–11.1)
Acidic pH
(2.5–3.0)
Neutral pH
(6.2–7.0)
Basic pH
(11.0–11.1)
NTR 7410 20.0 13.2 16.2 19.5 13.2 15.3 19.4 16.7 18.8
PAN GKSS HV3/T – – – – – – – – –
N 30 F 32.9 27.4 44.6 26.6 3.9 9.7 19.9 20.0 26.6
NF PES 10 6.9 2.5 5.5 18.1 2.6 17.5 31.1 2.6 28.4pHs some membranes may be electrically charged by an ionic
exchange with the solution: then repulsive or attractive
interactions between the substrate molecules and the membrane
surface may occur if the charges are of the same or of different
sign, respectively. Repulsive interactions increase rejection
values whereas attractive ones decrease them.
Table 5 shows some negative rejection values of the N 30 F
membrane toward ranitidine by changing pH and pressure
values. Indeed, only at DP = 8 bar and neutral and alkaline pHs
the rejection values are positive (20 and 26.6%, respectively).
The negative values of rejection can be explained by considering
strong adsorption phenomena of ranitidine onto N 30 F
membrane. Indeed, the results of an experimental run showed
that after ca. 22 h the average mass of ranitidine adsorbed by the
N 30 F membrane immersed in 200 mL of a 40 mg/L aqueous
solution of ranitidine (8 mg) was 1.07 mg, corresponding to
13.4% of the ranitidine present initially in solution.
The results of these rejection runs indicate that for
furosemide, the membranes which show the best performances
in terms of rejection percentages seem to be NF PES 10 at
alkaline pH followed by NTR 7410 at neutral and alkaline pHs
and by N 30 F at acidic pH, operating at pressures in the 4–8 bar
range. As far as ranitidine is concerned, NTR 7410 membrane
seems to be the best in all the pH range although its rejection at
P = 8 bar is slightly lower than that found for NF PES 10. The
advantage should be noticed, then, of operating with NTR 7410
at pressures lower than the highest one.
3.4. Photodegradation tests in the membrane photoreactor
In order to check the possible synergic effect when
heterogeneous photocatalysis and membrane technology arecoupled, rejection and photodegradation tests were carried out
simultaneously. One of the main advantage when a membrane
photoreactor is used instead of a ‘‘traditional’’ photoreactor,
can be found in the possibility of confining photocatalyst,
pollutants and intermediates in the reaction ambient, while the
treated water is obtained as permeate. Consequently the
performance of a suitable membrane should have a high
membrane water flux and a high rejection towards the
pollutants and the intermediates. The use of nanofiltration
membranes can allow these goals to be achieved if the
interaction between membrane and pollutants represents the
main mechanism regulating the rejection. For example, in some
cases, thanks to Donnan effect [36], it is possible to retain in the
reaction ambient molecules that otherwise can pass the
membrane by simply modifying the pH [37].
In this work the membrane NTR 7410 which is a good
compromise for the different drugs both at acidic and alkaline
pHs (see Table 4) was selected. The molecular weight cut-off of
this membrane is 600–800 g/mol, but charged molecules of
lower size can be also retained.
Among the seven pharmaceuticals the three ones with the
highest molecular weights (furosemide, ranitidine and oflox-
acine) were chosen to carry out the simultaneous rejection and
photodegradation tests.
Figs. 7 and 8 show the results of representative experimental
runs for furosemide and ranitidine carried out at acidic and
alkaline pHs, respectively. The concentrations of retentate and
permeate decrease during the photodegradation steps
(60 < t < 200 min). It can be noticed (Fig. 7) that some
figures of permeate concentrations under irradiation for both
substrates are higher than those of retentate. This insight is due
probably to the Donnan effect, a phenomenon of electrical
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Fig. 7. Substrate concentrations vs. time for runs carried out by using the hybrid
system with the NTR 7410 membrane at initial pH 3 (CTiO2 ¼ 1 g=L;
CO2 ¼ 22 ppm; immersed lamp 125 W). Furosemide: (*) retentate; (*)
permeate. Ranitidine: (&) retentate; (&) permeate.nature. During the run carried out with furosemide, the pH
decreased from 10.9 to 9.1 and the permeate flux was in the
range 43.4–44.9 L/(h m2) at acidic and alkaline pHs. As far as
ranitidine is concerned, the concentration of permeate and
retentate during the photodegradation step decreased of ca.
67% and 73% for acidic and alkaline conditions, respectively.
The pH changed from 3 to 5.2 during the irradiation time for the
run carried out at acidic pH whereas it changed from 10.9 to 8.8
for runs carried out at alkaline pH; the permeate flux was in the
range 43.4–49.0 L/(h m2) both at acidic and alkaline pHs.Fig. 8. Substrate concentrations vs. time for runs carried out by using the hybrid
system with the NTR 7410 membrane at initial pH 11 (CTiO2 ¼ 1 g=L;
CO2 ¼ 22 ppm; immersed lamp 125 W). Furosemide: (*) retentate; (*)
permeate. Ranitidine: (&) retentate; (&) permeate.The trend observed in Figs. 7 and 8 was the same also for
ofloxacine. It can be observed that rejection measured in the
presence of photocatalyst and oxygen, both in the dark and
under irradiation conditions, was almost 0, so that the
membrane in this case was beneficial only because it allowed
the confinement of the photocatalyst. This was not a useless
result because the costly separation of the catalyst from the
treated water can be avoided.
Nevertheless the maximum benefit when a photocatalytic
membrane reactor is used consists in retaining also the pollutant
in the reaction ambient as it was observed for humic acids and
some dyes [37]. Consequently further work is required to look
for other types of membranes, as for instance higher rejection
NF-type or low rejection reverse osmosis-type membranes, by
taking into account the relatively low molecular weight of the
drugs studied.
It is worth noting that most of the ions present in water could
pass through the membrane because the main aim of this
application would be only the removal of pharmaceutical
molecules contained as pollutants in aqueous effluent.
4. Conclusions
The photocatalytic degradation of pharmaceuticals such as
furosemide, ranitidine (hydrochloride), ofloxacine, phena-
zone, naproxen, carbamazepine and clofibric acid in a batch
photoreactor was carried out successfully. For furosemide,
ranitidine and ofloxacine a hybrid membrane photoreactor
was also used. While the photocatalyst was retained by the
membrane in the reaction ambient, the pollutant was not
satisfactory retained by the membrane. The flux through the
membrane NTR 7410 had an average value of 45 L/(h m2) at
both acidic and alkaline pHs. Rejection values were in the
range 10–60% for furosemide and 5–30% for ranitidine in the
dark (without photoreaction), but a net decrease down to 0
was observed in the contemporary presence of light,
photocatalyst and oxygen. Further investigation is in progress
to extend the benefit in the use of membrane photoreactors
not only to the catalyst confinement but also to the
confinement of drugs and their intermediates in the reaction
ambient.
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